Definitive Contract 75D30121C10991
- Not listed
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $789,188 firm fixed-price definitive contract to The Regents of the University of California, San Francisco (UCSF) for a project titled "FY22 BAA TOPIC 7 - UCSF." This contract, which has no set-aside designation, will run through September 25, 2024. UCSF, a public academic medical center and research university, will perform the work through its Controller's Office division. As a leading recipient of National...
- This is a $407,896 federal contract award to The Regents of the University of California, San Francisco (UCSF) by the Centers for Disease Control and Prevention (CDC). The contract is a definitive, cost-no-fee contract with a performance period ending on September 6, 2022. UCSF is a prominent academic medical center and research institution in San Francisco that provides specialized biomedical research, healthcare services, and educational programs to federal agencies through competitive...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF), a leading academic medical center and research institution. The contract, valued at $300,058, is for other functions and is a definitive, firm-fixed-price contract. It does not have a set-aside designation. The contract work is being performed in Atlanta, Georgia and has an ultimate completion date of December 31, 2018. UCSF has a strong...
- The Centers for Disease Control and Prevention (CDC) awarded The Regents of the University of California, San Francisco (UCSF) a $6,115,923.22 definitive cost-no-fee contract for the "National History of SARS-CoV-2 Infection" project. The contract has a completion date of May 31, 2024. UCSF, a public academic medical center and research university, has a long history of conducting biomedical research, clinical trials, and providing healthcare and technical services under federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,724,262 definitive cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for the Tuberculosis Trials Consortium. The contract has a completion date of December 31, 2021 and is not set aside for any special program. UCSF is an academic institution that has previously received federal contracts and grants from agencies such as the National Institutes of Health,...
- This is a $152,588.29 firm fixed-price purchase order contract awarded by the Office of Logistics and Acquisition Operations (part of the U.S. Department of Health and Human Services) to the University of California, San Francisco (UCSF). The contract is not set aside for any specific category. UCSF is a prominent academic medical center and research institution with a strong track record of securing federal contracts and grants, particularly from agencies like the National Institutes of Health,...
- This is a $100,000.00 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF) for Bartonella serum samples. The contract has an ultimate completion date of September 14, 2023 and was awarded on September 16, 2022 without any set-aside designation. UCSF is a leading academic medical center and research institution that frequently partners with federal agencies such as the CDC to...
- The Department of Health and Human Services National Institutes of Health awarded a definitive, cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for $6,657,300.68. The contract is for biomedical (basic) services and does not have a set-aside designation. UCSF, a public academic medical center and research university, is providing services through its Controller's Office division. The contract commenced on September 30, 2004 and is scheduled for completion...
- This $89,701.75 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to the Regents of the University of California, San Francisco (UCSF) on August 28, 2023. The contract is for exposure to illicit drugs urine analysis services, with a period of performance running through April 22, 2025. UCSF is a prominent academic medical center and research institution that has demonstrated significant capabilities in securing federal contracts and grants across...
- This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF) for the "PRIDE POPULATION RESEARCH IN IDENTITY AND DISPARITIES FOR EQUALITY" program. The contract has a ceiling value of $48,503.54 and an ultimate completion date of February 14, 2025. UCSF is a prominent academic medical center and research institution that has demonstrated significant capabilities...
This is a $653,563.97 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, San Francisco (UCSF) on May 15, 2021. The contract is for FY21 BAA TOPIC 8 - UCSF 8.2 and does not have a set-aside designation. UCSF, a public academic medical center and research university, will be providing research services to the CDC through this contract, which has a performance period ending on May 14, 2023. UCSF has a history of partnering with federal agencies like the Department of Defense, National Institutes of Health, and Department of Veterans Affairs on various research projects and clinical trials. The Regents of the University of California, which oversees UCSF, has also received numerous federal grants and contracts as both a prime and subcontractor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($88) | 4/4/24 | |
| P00001 | Other Administrative Action | $0 | 1/26/23 | |
| Not listed | Not listed | $653.7k | 5/4/21 |